Floatz logo

215 assets in Castration-Resistant Prostate Carcinoma

Therapeutic assets addressing Castration-Resistant Prostate Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Etx-19477
Castration-Resistant Prostate Carcinoma
858 Therapeutics, Inc.P1/2CC (47)
Ifinatamab Deruxtecan
Castration-Resistant Prostate Carcinoma
Merck Sharp & Dohme LLCP1/2CC (47)
mhb048c for
Castration-Resistant Prostate Carcinoma
Minghui Pharmaceutical (Hangzhou) LtdP1/2CC (47)
Midazolam
Castration-Resistant Prostate Carcinoma
Aragon Pharmaceuticals, Inc.P1CC (47)
mk-5684
Castration-Resistant Prostate Carcinoma
Merck Sharp & Dohme LLCP1/2CC (47)
pd1-psma-cart cells
Castration-Resistant Prostate Carcinoma
Zhejiang UniversityP1CC (47)
Pioglitazone
Castration-Resistant Prostate Carcinoma
Aragon Pharmaceuticals, Inc.P1CC (47)
Pocenbrodib
Castration-Resistant Prostate Carcinoma
Pathos AI, Inc.P1/2CC (47)
tt-10
Castration-Resistant Prostate Carcinoma
Portage BiotechP1/2CC (47)
tt-4
Castration-Resistant Prostate Carcinoma
Portage BiotechP1/2CC (47)
Warfarin
Castration-Resistant Prostate Carcinoma
Aragon Pharmaceuticals, Inc.P1CC (47)
xnw5004
Castration-Resistant Prostate Carcinoma
Evopoint Biosciences Inc.P1/2CC (47)
177lu-dansyl-psma radioligand therapy
Castration-Resistant Prostate Carcinoma
The First Affiliated Hospital of Xiamen UniversityP1CC (46)
Gedatolisib
Castration-Resistant Prostate Carcinoma
Celcuity IncP1/2CC (46)
prt2527
Castration-Resistant Prostate Carcinoma
Prelude TherapeuticsP1CC (46)
161tb rad402
Castration-Resistant Prostate Carcinoma
Radiopharm Theranostics, LtdP1/2CC (45)
67cu-sar-bispsma
Castration-Resistant Prostate Carcinoma
Clarity Pharmaceuticals LtdP1/2CC (45)
Gamma1 Heavy Chain Humanized (1-450) [Vh (Homo Sapiens Ighv4-31*01 (89.9%) -(Ighd) -Ighj4*01 (92.9%), Cdr-Imgt [9.7.13] (26-34.52-58.97-109)) (1-120) -Homo Sapiens Ighg1*01 (100%), G1M17,1 Ch1 K120, D12, L14 (Ch1 K120 (217) (121-218), Hinge 1-15 (219-233), Ch2 (234-343), Ch3 D12 (359), L14 (361) (344-448), Chs (449-450)) (121-450)], (223-214')-Disulfide With Kappa Light Chain Humanized (1'-214') [V-Kappa (Homo Sapiens Igkv1-12*01 (85.3%)-Igkj2*01 (100%), Cdr-Imgt [6.3.9] (27-32.50-52.89-97)) (1'-107') -Homo Sapiens Igkc*01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')]; Dimer (229-229'':232-232'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Derived From The Cell Line Cho-K1,Glycoform Alfa
Castration-Resistant Prostate Carcinoma
Cancer Research UKP1/2CC (45)
htl0039732 capsules
Castration-Resistant Prostate Carcinoma
Cancer Research UKP1/2CC (45)
Sar-Bispsma, Cu-64
Castration-Resistant Prostate Carcinoma
Clarity Pharmaceuticals LtdP1/2CC (45)
Tulmimetostat
Castration-Resistant Prostate Carcinoma
Novartis PharmaceuticalsP1/2CC (45)
Valemetostat
Castration-Resistant Prostate Carcinoma
M.D. Anderson Cancer CenterP1CC (44)
Vobramitamab Duocarmazine
Castration-Resistant Prostate Carcinoma
MacroGenicsP2CC (44)
Xmab808
Castration-Resistant Prostate Carcinoma
Xencor, Inc.P1CC (44)
161tb-psma-i&t
Castration-Resistant Prostate Carcinoma
National Taiwan University HospitalP1CC (43)
177lu-lnc1003
Castration-Resistant Prostate Carcinoma
Yantai LNC Biotechnology Singapore PTE. LTD.P1CC (43)
177lu-psma
Castration-Resistant Prostate Carcinoma
Peter MacCallum Cancer Centre, AustraliaP1CC (43)
177lu-psma-0057
Castration-Resistant Prostate Carcinoma
Chengdu StarRay Therapeutics Co., LtdP1/2CC (43)
²¹²pb-dotam-grpr1
Castration-Resistant Prostate Carcinoma
Orano Med Theranostics, SASP1CC (43)
[225Ac]Ac-AKY-2519
Castration-Resistant Prostate Carcinoma
Aktis Oncology, Inc.P1CC (43)
225ac-psma-trillium
Castration-Resistant Prostate Carcinoma
BayerP1CC (43)
225ac-psma-xt
Castration-Resistant Prostate Carcinoma
Xiaorong SunP1CC (43)
[64Cu]Cu-AKY-2519
Castration-Resistant Prostate Carcinoma
Aktis Oncology, Inc.P1CC (43)
-9bms
Castration-Resistant Prostate Carcinoma
TechnoGenesys, Inc.P1CC (43)
Ace-232 Tablets
Castration-Resistant Prostate Carcinoma
Acerand Therapeutics (Hong Kong) LimitedP1CC (43)
Amoxicillin
Castration-Resistant Prostate Carcinoma
Institute of Cancer Research, United KingdomP1/2CC (43)
Apg-5918
Castration-Resistant Prostate Carcinoma
Ascentage Pharma Group Inc.P1CC (43)
Autologous Neoantigen-Pulsed Dendritic Cell Vaccine
Castration-Resistant Prostate Carcinoma
Changhai HospitalP1CC (43)
cc-1, psmaxcd3
Castration-Resistant Prostate Carcinoma
University Hospital TuebingenP1CC (43)
Ciprofloxacin
Castration-Resistant Prostate Carcinoma
Institute of Cancer Research, United KingdomP1/2CC (43)
Dcc-3084
Castration-Resistant Prostate Carcinoma
Deciphera Pharmaceuticals, LLCP1CC (43)
dr-0202
Castration-Resistant Prostate Carcinoma
Dren BioP1CC (43)
ep31670
Castration-Resistant Prostate Carcinoma
Epigenetix, Inc.P1CC (43)
erw316
Castration-Resistant Prostate Carcinoma
Novartis PharmaceuticalsP1/2CC (43)
Etb-Dualnk-01
Castration-Resistant Prostate Carcinoma
Beijing BiotechP1CC (43)
Flavone, 3,3',4',5,7-Pentahydroxy-
Castration-Resistant Prostate Carcinoma
Charles Drew University of Medicine and ScienceP1/2CC (43)
Green Tea Leaf Extract Decaffeinated
Castration-Resistant Prostate Carcinoma
Charles Drew University of Medicine and ScienceP1/2CC (43)
ide574
Castration-Resistant Prostate Carcinoma
IDEAYA BiosciencesP1CC (43)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer
Castration-Resistant Prostate Carcinoma
Regeneron PharmaceuticalsP1/2CC (43)
Ivuxolimab
Castration-Resistant Prostate Carcinoma
M.D. Anderson Cancer CenterP1/2CC (43)
Showing 101 to 150 of 215 assets
PreviousPage 3 of 5Next